We recently traveled to Dallas, Texas for a State of the Science Summit on Non–Small Cell Lung Cancer. At the meeting, faculty from Baylor Scott and White Health System highlighted headway made in the treatment landscapes of non–small cell lung cancer according to histology, stage, and treatment intervention, the likes of which now include immunotherapy, targeted therapy, and chemotherapy.